Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium.

Johnatty SE, Beesley J, Chen X, Spurdle AB, Defazio A, Webb PM; Australian Ovarian Cancer Study Group; Australian Cancer Study (Ovarian Cancer), Goode EL, Rider DN, Vierkant RA, Anderson S, Wu AH, Pike M, Van Den Berg D, Moysich K, Ness R, Doherty J, Rossing MA, Pearce CL, Chenevix-Trench G.

Twin Res Hum Genet. 2009 Jun;12(3):269-75. doi: 10.1375/twin.12.3.269.

2.

Genetic variants in the fibroblast growth factor pathway as potential markers of ovarian cancer risk, therapeutic response, and clinical outcome.

Meng QH, Xu E, Hildebrandt MA, Liang D, Lu K, Ye Y, Wagar EA, Wu X.

Clin Chem. 2014 Jan;60(1):222-32. doi: 10.1373/clinchem.2013.211490. Epub 2013 Oct 21.

3.

Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer.

Schildkraut JM, Iversen ES, Wilson MA, Clyde MA, Moorman PG, Palmieri RT, Whitaker R, Bentley RC, Marks JR, Berchuck A.

PLoS One. 2010 Apr 8;5(4):e10061. doi: 10.1371/journal.pone.0010061.

4.

Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the Breast Cancer Health Disparities Study.

Slattery ML, John EM, Stern MC, Herrick J, Lundgreen A, Giuliano AR, Hines L, Baumgartner KB, Torres-Mejia G, Wolff RK.

Breast Cancer Res Treat. 2013 Aug;140(3):587-601. doi: 10.1007/s10549-013-2644-5. Epub 2013 Aug 3.

5.

MTHFR polymorphisms in relation to ovarian cancer risk.

Terry KL, Tworoger SS, Goode EL, Gates MA, Titus-Ernstoff L, Kelemen LE, Sellers TA, Hankinson SE, Cramer DW.

Gynecol Oncol. 2010 Nov;119(2):319-24. doi: 10.1016/j.ygyno.2010.08.007.

6.

STK15 polymorphisms and association with risk of invasive ovarian cancer.

Dicioccio RA, Song H, Waterfall C, Kimura MT, Nagase H, McGuire V, Hogdall E, Shah MN, Luben RN, Easton DF, Jacobs IJ, Ponder BA, Whittemore AS, Gayther SA, Pharoah PD, Kruger-Kjaer S.

Cancer Epidemiol Biomarkers Prev. 2004 Oct;13(10):1589-94.

7.

Common variation in EMSY and risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs.

Benusiglio PR, Lesueur F, Luccarini C, McIntosh J, Luben RN, Smith P, Dunning A, Easton DF, Ponder BA, Pharoah PD.

BMC Cancer. 2005 Jul 19;5:81.

8.

Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in relation to ovarian cancer risk and survival.

Williams KA, Terry KL, Tworoger SS, Vitonis AF, Titus LJ, Cramer DW.

PLoS One. 2014 Feb 13;9(2):e88334. doi: 10.1371/journal.pone.0088334. eCollection 2014.

9.

Association between genetic polymorphisms in fibroblast growth factor (FGF)1 and FGF2 and risk of endometriosis and adenomyosis in Chinese women.

Kang S, Li SZ, Wang N, Zhou RM, Wang T, Wang DJ, Li XF, Bui J, Li Y.

Hum Reprod. 2010 Jul;25(7):1806-11. doi: 10.1093/humrep/deq128. Epub 2010 May 26.

PMID:
20504870
10.

Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium.

Kelemen LE, Bandera EV, Terry KL, Rossing MA, Brinton LA, Doherty JA, Ness RB, Kjaer SK, Chang-Claude J, Köbel M, Lurie G, Thompson PJ, Carney ME, Moysich K, Edwards R, Bunker C, Jensen A, Høgdall E, Cramer DW, Vitonis AF, Olson SH, King M, Chandran U, Lissowska J, Garcia-Closas M, Yang H, Webb PM, Schildkraut JM, Goodman MT, Risch HA; Australian Ovarian Cancer Study Group and Australian Cancer Study (Ovarian Cancer); Ovarian Cancer Association Consortium.

BMC Cancer. 2013 Jan 22;13:28. doi: 10.1186/1471-2407-13-28.

11.

Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism.

Goodman MT, McDuffie K, Kolonel LN, Terada K, Donlon TA, Wilkens LR, Guo C, Le Marchand L.

Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3):209-16.

12.

Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility.

Yang CQ, Chan KY, Ngan HY, Khoo US, Chiu PM, Chan QK, Xue WC, Cheung AN.

Carcinogenesis. 2006 Jul;27(7):1502-6. Epub 2006 Mar 30.

PMID:
16574671
13.

Inherited common variants in mitochondrial DNA and invasive serous epithelial ovarian cancer risk.

Earp MA, Brooks-Wilson A, Cook L, Le N.

BMC Res Notes. 2013 Oct 22;6:425. doi: 10.1186/1756-0500-6-425.

14.

Common variation in Nemo-like kinase is associated with risk of ovarian cancer.

Stevens KN, Kelemen LE, Wang X, Fridley BL, Vierkant RA, Fredericksen Z, Armasu SM, Tsai YY, Berchuck A, Narod SA, Phelan CM, Sutphen R, Birrer MJ, Schildkraut JM, Sellers TA, Goode EL; Ovarian Cancer Association Consortium, Couch FJ.

Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):523-8. doi: 10.1158/1055-9965.EPI-11-0797. Epub 2012 Jan 17.

15.

Folate and related micronutrients, folate-metabolising genes and risk of ovarian cancer.

Webb PM, Ibiebele TI, Hughes MC, Beesley J, van der Pols JC, Chen X, Nagle CM, Bain CJ, Chenevix-Trench G; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group.

Eur J Clin Nutr. 2011 Oct;65(10):1133-40. doi: 10.1038/ejcn.2011.99. Epub 2011 Jun 1.

PMID:
21629268
16.

Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer.

Wenham RM, Schildkraut JM, McLean K, Calingaert B, Bentley RC, Marks J, Berchuck A.

Clin Cancer Res. 2003 Oct 1;9(12):4396-403.

17.

Genetic polymorphisms in AURKA, BRCA1, CCNE1 and CDK2 are associated with ovarian cancer susceptibility among Chinese Han women.

Zheng L, Song A, Ruan Y, Chen L, Liu D, Li X, Guo H, Han J, Li Y, Tian X, Fang W.

Cancer Epidemiol. 2013 Oct;37(5):639-46. doi: 10.1016/j.canep.2013.04.018. Epub 2013 Jun 18.

PMID:
23787073
18.

Association of a common variant of SYNPO2 gene with increased risk of serous epithelial ovarian cancer.

Ma L, Zhang W, Ding Z, Wu SG, Jin Y, Jiang N, Du H, Cai D, Miao L, Chen X.

Tumour Biol. 2017 Feb;39(2):1010428317691185. doi: 10.1177/1010428317691185.

PMID:
28231729
19.

Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer.

Polnaszek N, Kwabi-Addo B, Peterson LE, Ozen M, Greenberg NM, Ortega S, Basilico C, Ittmann M.

Cancer Res. 2003 Sep 15;63(18):5754-60.

20.

Associations of Plasma FGF2 Levels and Polymorphisms in the FGF2 Gene with Obesity Phenotypes in Han Chinese Population.

Hao RH, Guo Y, Dong SS, Weng GZ, Yan H, Zhu DL, Chen XF, Chen JB, Yang TL.

Sci Rep. 2016 Feb 16;6:19868. doi: 10.1038/srep19868.

Supplemental Content

Support Center